Skip to main content

BEAUTY OF FINE DOTS

Detection and treatment of Alzheimer's disease using quantum dots

  • Conference paper
  • First Online:
CMBEBIH 2017

Part of the book series: IFMBE Proceedings ((IFMBE,volume 62))

  • 4303 Accesses

Abstract

This paper presents a review on available researches, when it comes to the usage of quantum dots in detection and treatment of the most common form of dementia, and that is Alzheimer’s disease (AD). Quantum dots (QDs), as an essential material of nanotechnology, give unique approaches and solutions for preventing and curing AD. In this paper, CdSe/ZnS quantum dots and their application features are analyzed and proposed as the possible solution for inhibition of events in the organism, that occur before the patients show visible symptoms.

Scientists around the world truly believe, that nanotechnology in fact is the future of medicine and that this emerging technology, although still in a “newborn” state, would provide answers for the treatment of many to this date incurable disease, as AD itself. Discussed approaches are still in an experimental phase, because the possible toxicology of many nanomaterials isn’t fully investigated.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. E. R. Cobarrubia, “Alzheimer’s Disease and Nanotechnology,” 2013.

    Google Scholar 

  2. King’s College London, “The global impact of dementia,” Alzheimer’s Disease International, 2015. [Online]. Available: http://www.alz.co.uk/sites/default/files/pdfs/global-impact-dementia-infographic.pdf. [Accessed 23 October 2016].

  3. W. J. Lukiw, “Alzheimer’s disease (AD) as a disorder of the plasma membrane,” Frontiers in Phisiology, vol. 4, pp. 4-24, 2013.

    Google Scholar 

  4. G. Thakur, M. Micic, Y. Yang, W. Li, D. Movia, S. Giordani, H. Zhang and R. M. Leblanc, “Conjugated Quantum Dots Inhibit the Amyloid ß (1-42) Fibrillation Process,” International Journal of Alzheimer’s Disease, vol. 2011, p. 15, 2011.

    Google Scholar 

  5. P. Seeman and N. Seeman, “Alzheimer’s disease: β-amyloid plaque formation in human brain,” Synapse, vol. 65, no. 12, pp. 1289-1297, 2011.

    Google Scholar 

  6. M. Shilo, A. Sharon, K. Baranes, M. Motiei, J.-P. M. Lellouche and R. Popovtzer, “The effect of nanoparticle size on the probability to cross the blood-brain barrier: an in-vitro endothelial cell model,” Journal of Nanobiotechnology, pp. 13-19, 2015.

    Google Scholar 

  7. G. Mahajan, “Fighting Alzheimer’s disease with nanotechnology,” Nanowerk, 13 Decembre 2011. [Online]. Available: http://www.nanowerk.com/spotlight/spotid=23726.php. [Accessed September 2016].

  8. M. G. De Morais, V. G. Martins, D. Steffens, P. Pranke and J. A. V. Da Costa, “Biological Applications of Nanobiotechnology,” Journal of Nanoscience and Nanotechnology, vol. 14, no. 1, pp. 1007-1017, 2014.

    Google Scholar 

  9. D. Zherebetskyy, M. Scheele, Y. Zhang, N. Bronstein, C. Thompson, D. Britt, M. Salmeron, P. Alivisatos and L.-W. Wang, “Hydroxylation of the surface of PbS nanocrystals passivated with oleic acid,” Science, vol. 344, no. 6190, pp. 1380-1384, 2014.

    Google Scholar 

  10. K. Lugo, X. Miao, F. Rieke and L. Y. Lin, “Remote switching of cellular activity and cell signaling using light in conjunction with quantum dots,” Biomedical Optics Express, vol. 3, no. 3, 2012.

    Google Scholar 

  11. A. Nazem and G. A. Mansoori, “Nanotechnology for Alzheimer’s disease detection and treatment,” Insciences Journal, pp. 169-193, 2011.

    Google Scholar 

  12. B. J. Blanchard, B. R. Stockwell and V. M. Ingram, “Eliminating membrane depolarization caused by the Alzheimer peptide Aβ(1-42, aggr.),” Biochemical and Biophysical Research Communications, vol. 293, no. 4, pp. 1204-1208, 2002.

    Google Scholar 

  13. M. A. Mukhamedyarov, S. N. Grishin, E. R. Yusupova, A. L. Zefirov and A. Palotas, “Alzheimer’s β-Amyloid-Induced Depolarization of Skeletal Muscle Fibers: Implications for Motor Dysfunctions in Dementia,” Cellular Physiology and Biochemistry, vol. 23, pp. 109-114, 2009.

    Google Scholar 

  14. M. Fakruddin, Z. Hossain and H. Afroz, “Prospects and applications of nanobiotechnology: a medical perspective,” Journal of Nanobiotechnology, pp. 10-31, 2012.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anida Devedžić .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Nature Singapore Pte Ltd.

About this paper

Cite this paper

Devedžić, A. (2017). BEAUTY OF FINE DOTS. In: Badnjevic, A. (eds) CMBEBIH 2017. IFMBE Proceedings, vol 62. Springer, Singapore. https://doi.org/10.1007/978-981-10-4166-2_24

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-4166-2_24

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-4165-5

  • Online ISBN: 978-981-10-4166-2

  • eBook Packages: EngineeringEngineering (R0)

Publish with us

Policies and ethics